2024-01-30 07:24:33 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)
- Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade)
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Big Pharma earnings season in spotlight amid positive sentiment
- Regeneron/ Sanofi win label expansion for Dupixent in esophageal disorder
Read the full article on Seeking Alpha
For further details see:
2seventy stock rises as Regeneron acquires R&D assets